Vivo Bio Tech Limited (BOM:511509)
India · Delayed Price · Currency is INR 19.31
-0.02 (-0.10%)
At close: Aug 21, 2026
Vivo Bio Tech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -17.09 | 72.83 | 25.26 | 26.49 | 22.02 |
Depreciation & Amortization | 106.27 | 69.3 | 71.98 | 71.68 | 59.32 |
Other Amortization | - | 20.86 | 20.93 | 20.97 | 15.14 |
Loss (Gain) From Sale of Assets | - | -46.15 | - | - | - |
Other Operating Activities | 97.71 | 54.68 | 62.53 | 62.84 | 28.11 |
Change in Accounts Receivable | 136.75 | 52.33 | -154.26 | -61.55 | 12.51 |
Change in Accounts Payable | 25.66 | -105.57 | 128.78 | 27.9 | 29.32 |
Operating Cash Flow | 349.31 | 118.28 | 155.22 | 148.34 | 166.42 |
Operating Cash Flow Growth | 195.32% | -23.80% | 4.64% | -10.87% | 17.40% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -374.38 | -222.7 | -79.5 | -39.98 | -511.12 |
Sale of Property, Plant & Equipment | - | 64.29 | - | - | - |
Investment in Securities | -219.1 | - | - | - | - |
Investing Cash Flow | -593.48 | -158.42 | -79.5 | -39.98 | -511.12 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 116.72 | - | - | - | 354.29 |
Long-Term Debt Repaid | - | -68.5 | -13.04 | -69.87 | - |
Net Debt Issued (Repaid) | 116.72 | -68.5 | -13.04 | -69.87 | 354.29 |
Issuance of Common Stock | 169.62 | 89.51 | - | 27.86 | 31.37 |
Other Financing Activities | -40.63 | 18.04 | -62.53 | -69.74 | -35.48 |
Financing Cash Flow | 245.72 | 39.05 | -75.57 | -111.75 | 350.18 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 |
Net Cash Flow | 1.55 | -1.09 | 0.15 | -3.39 | 5.48 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -25.07 | -104.42 | 75.72 | 108.36 | -344.7 |
Free Cash Flow Growth | - | - | -30.12% | - | - |
Free Cash Flow Margin | -4.70% | -22.37% | 16.66% | 20.75% | -67.07% |
Free Cash Flow Per Share | -1.20 | -6.83 | 4.54 | 7.31 | -24.34 |
Levered Free Cash Flow | -93.18 | -34.6 | -105.99 | 18.8 | -390.38 |
Unlevered Free Cash Flow | -56.63 | 12.3 | -57.37 | 66.62 | -365.42 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 58.49 | 75.04 | 77.78 | 76.51 | 39.93 |
Cash Income Tax Paid | 8.1 | 15.1 | 15.34 | 19.72 | 22.71 |
Change in Working Capital | 162.42 | -53.24 | -25.48 | -33.65 | 41.83 |